Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPO to Protect Renal Function After Cardiac Surgery. A Phase II Double Blind Randomized Controlled Study.

NCT01423955 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT01423955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01423955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPO to Protect Renal Function After Cardiac Surgery. A Phase II Double Blind Randomized Controlled Study.
Lead sponsor
Region Skane
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
April 30, 2013
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, renal failure